FDA Inspection
Novacyl (Thailand) Ltd.Novacyl (Thailand) Ltd. – FDA Inspection, Mar 23, 2018
Record Details
This FDA Inspection record concerns Novacyl (Thailand) Ltd., with an inspection on March 23, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f8d79f17-d80e-450d-96d8-b36f0f26fb20
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1048663
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Novacyl (Thailand) Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 25, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 8, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novacyl (Thailand) Ltd.
- FDA Inspection 1287228 - 2023-04-28
- FDA Inspection 1135087 - 2019-03-14
- FDA Inspection 950771 - 2015-11-20
- FDA Inspection 879464 - 2014-04-25
- FDA Inspection 674862 - 2010-07-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.